ASCN 📈 Ascom Holding - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0011339204
ASCN: Nurse Call Systems, Workflow Software, Mobile Devices, Consulting Services
Ascom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. The company offers nurse call and monitoring systems, including teleCARE IP that provides wireless nurse call, alerts, messaging, monitoring, and wander management solution; and Telligence, a patient response system. It also provides Digistat, a suite of clinical workflow software; Unite software, a workflow orchestration platform that integrates data and events from source systems, as well as offers alerts, chats, and tasks to enable users on various endpoint platforms; and Ofelia for managing tasks and workflows. In addition, the company offers mobile devices, such as smartphones, DECT and VoWiFi phones, and pagers solutions. Further, it offers consulting, implementation, training, support, and maintenance services. The company was incorporated in 1996 and is headquartered in Baar, Switzerland. Web URL: https://www.ascom.com
Additional Sources for ASCN Stock
ASCN Stock Overview
| Market Cap in USD | 166m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
ASCN Stock Ratings
| Growth 5y | -72.7% |
| Fundamental | 68.8% |
| Dividend | 37.1% |
| Rel. Strength Industry | -2073 |
| Analysts | - |
| Fair Price Momentum | 3.27 CHF |
| Fair Price DCF | 18.08 CHF |
ASCN Dividends
| Dividend Yield 12m | 7.50% |
| Yield on Cost 5y | 3.03% |
| Annual Growth 5y | -14.97% |
| Payout Consistency | 45.6% |
ASCN Growth Ratios
| Growth Correlation 3m | -94.9% |
| Growth Correlation 12m | -73.5% |
| Growth Correlation 5y | -45.5% |
| CAGR 5y | -16.37% |
| CAGR/Mean DD 5y | -0.47 |
| Sharpe Ratio 12m | -2.12 |
| Alpha | -72.49 |
| Beta | 0.91 |
| Volatility | 28.52% |
| Current Volume | 44k |
| Average Volume 20d | 74.4k |
What is the price of ASCN stocks?
As of December 22, 2024, the stock is trading at CHF 4.03 with a total of 44,034 shares traded.
Over the past week, the price has changed by -2.91%, over one month by -4.99%, over three months by -27.67% and over the past year by -46.01%.
As of December 22, 2024, the stock is trading at CHF 4.03 with a total of 44,034 shares traded.
Over the past week, the price has changed by -2.91%, over one month by -4.99%, over three months by -27.67% and over the past year by -46.01%.
Is Ascom Holding a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Ascom Holding (SW:ASCN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.79 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASCN as of December 2024 is 3.27. This means that ASCN is currently overvalued and has a potential downside of -18.86%.
Yes, based on ValueRay Fundamental Analyses, Ascom Holding (SW:ASCN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.79 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASCN as of December 2024 is 3.27. This means that ASCN is currently overvalued and has a potential downside of -18.86%.
Is ASCN a buy, sell or hold?
Ascom Holding has no consensus analysts rating.
Ascom Holding has no consensus analysts rating.
What are the forecast for ASCN stock price target?
According to ValueRays Forecast Model, ASCN Ascom Holding will be worth about 3.6 in December 2025. The stock is currently trading at 4.03. This means that the stock has a potential downside of -9.93%.
According to ValueRays Forecast Model, ASCN Ascom Holding will be worth about 3.6 in December 2025. The stock is currently trading at 4.03. This means that the stock has a potential downside of -9.93%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 6.7 | 65% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.6 | -9.9% |